Manulife (Manufacturers Life Insurance)
RNAC icon

Manulife (Manufacturers Life Insurance)’s Cartesian Therapeutics RNAC Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-736
Closed -$23.4K – 3013
2023
Q3 		$23.4K Buy
+736
New +$24.6K ﹤0.01% 2956
2022
Q2 		– Sell
-1,441
Closed -$53.2K – 3119
2022
Q1 		$53.2K Sell
1,441
-273
-16% -$17.1K ﹤0.01% 3036
2021
Q4 		$168 Buy
1,714
+44
+3% +$4.73K ﹤0.01% 2955
2021
Q3 		$208K Sell
1,670
-112
-6% -$13.5K ﹤0.01% 2958
2021
Q2 		$223K Buy
1,782
+371
+26% +$44.2K ﹤0.01% 3025
2021
Q1 		$192K Sell
1,411
-99
-7% -$12.3K ﹤0.01% 2907
2020
Q4 		$137K Buy
1,510
+67
+5% +$5.81K ﹤0.01% 2895
2020
Q3 		$107K Hold
1,443
– – ﹤0.01% 2781
2020
Q2 		$122K Buy
+1,443
New +$131K ﹤0.01% 2686
2019
Q2 		– Sell
-389
Closed -$28K – 2953
2019
Q1 		$28K Buy
+389
New +$24.7K ﹤0.01% 2613
2018
Q3 		– Sell
-534
Closed -$213K – 3701
2018
Q2 		$213K Buy
534
+471
+748% +$167K ﹤0.01% 3083
2018
Q1 		$19K Sell
63
-47
-43% -$13.4K ﹤0.01% 3765
2017
Q4 		$33K Sell
110
-292
-73% -$128K ﹤0.01% 3652
2017
Q3 		$219K Buy
402
+27
+7% +$14.4K ﹤0.01% 2910
2017
Q2 		$224K Buy
375
+335
+838% +$148K ﹤0.01% 2915
2017
Q1 		$17K Buy
40
+38
+1,900% +$16K ﹤0.01% 3568
2016
Q4 		$1K Buy
+2
New +$1.17K ﹤0.01% 4216

Other funds holding RNAC

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s RNAC Position: Q4 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Cartesian Therapeutics (RNAC) in Q4 2023, closing a stake of 736 shares — an estimated $23.4K sold.

Manulife (Manufacturers Life Insurance) first reported a position in RNAC in Q4 2016 and held it in 17 quarters. The position peaked at $224K in Q2 2017. 80 funds tracked by Wall St. Rank hold RNAC as of Q4 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining Cartesian Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 736 Cartesian Therapeutics shares in Q4 2023, an estimated $23.4K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Cartesian Therapeutics in Q4 2016 and held it in 17 quarters.
  • Manulife (Manufacturers Life Insurance)'s Cartesian Therapeutics position peaked at $224K in Q2 2017.
  • 80 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q4 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2023, filed 13 Feb 2024.